| Q36494079 | A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines |
| Q33784968 | A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection. |
| Q34468330 | AAV2-mediated in vivo immune gene therapy of solid tumours |
| Q33825265 | Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response |
| Q45002920 | Analysis of DNA-vaccinated fish reveals viral antigen in muscle, kidney and thymus, and transient histopathologic changes |
| Q73393090 | Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination |
| Q34451949 | Anticytokine gene therapy of autoimmune diseases |
| Q44581978 | Assessment of DNA vaccine potential for gilthead sea bream (Sparus aurata) by intramuscular injection of a reporter gene. |
| Q37725427 | Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection |
| Q37001971 | CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses |
| Q33908929 | Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins |
| Q37642130 | Circulating smooth muscle progenitor cells in atherosclerosis and plaque rupture: current perspective and methods of analysis. |
| Q40124936 | Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine |
| Q42228115 | Combination of MIDGE-Th1 DNA vaccines with the cationic lipid SAINT-18: studies on formulation, biodistribution and vector clearance |
| Q33783905 | Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles |
| Q33597242 | CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice |
| Q33783789 | DNA and RNA-based vaccines: principles, progress and prospects |
| Q62748480 | DNA immunisation: altering the cellular localisation of expressed protein and the immunisation route allows manipulation of the immune response |
| Q33589130 | DNA immunization: mechanistic studies |
| Q40828806 | DNA immunization: present and future |
| Q74586095 | DNA is as effective as protein at inducing antibody in fish |
| Q33822028 | DNA vaccines against cancer: from genes to therapy. |
| Q33646672 | DNA vaccines for viral diseases |
| Q73265847 | DNA vaccines for viral diseases |
| Q33765876 | DNA vaccines: a review |
| Q34570728 | DNA vaccines: future strategies and relevance to intracellular pathogens |
| Q33537293 | DNA vaccines: technology and application as anti-parasite and anti-microbial agents |
| Q77930082 | DNA-antiviral vaccines: new developments and approaches--a review |
| Q44567701 | DNA-based immunization against hepatitis B virus |
| Q45750932 | DNA-mediated immunization to hepatitis B virus envelope proteins: preS antigen secretion enhances the humoral response. |
| Q44467204 | Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes |
| Q43873068 | Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters |
| Q34326453 | Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice |
| Q45879455 | Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies |
| Q41363923 | Employing XIAP to enhance the duration of antigen expression and immunity against an avian influenza H5 DNA vaccine |
| Q27469698 | Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. |
| Q40499124 | Evaluation of different chemical adjuvants on an avian influenza H6 DNA vaccine in chickens |
| Q52020934 | Expansion of HBV-specific memory CTL primed by dual HIV/HBV genetic immunization during SHIV primary infection in rhesus macaques. |
| Q27469367 | Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization. |
| Q33324150 | Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression |
| Q41724485 | Gene vaccination: plasmid DNA is more than just a blueprint |
| Q33591476 | Genetic vaccines |
| Q84573785 | HIV-1 derived peptides fused to HBsAg affect its immunogenicity |
| Q35143267 | Haemolysin A and listeriolysin--two vaccine delivery tools for the induction of cell-mediated immunity |
| Q40794617 | Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. |
| Q34111739 | Imaging of light emission from the expression of luciferases in living cells and organisms: a review |
| Q45871042 | Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice |
| Q45873428 | Immune response at birth, long-term immune memory and 2 years follow-up after in-utero anti-HBV DNA immunization. |
| Q39589794 | Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization |
| Q45880067 | Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms |
| Q45031334 | Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation |
| Q73224180 | Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence |
| Q45886869 | Intramuscular immunization with plasmid coexpressing tumour antigen and Flt-3L results in potent tumour regression |
| Q54612588 | Long-term persistence of hepatitis B surface antigen and antibody induced by DNA-mediated immunization results in liver and kidney lesions in mice. |
| Q77419304 | Mammalian granulocyte-macrophage colony-stimulating factor and some CpG motifs have an effect on the immunogenicity of DNA and subunit vaccines in fish |
| Q33804080 | Mucosal immunization with DNA vaccines |
| Q30726038 | Novel vaccine strategies to T-independent antigens |
| Q36435304 | On DNA vaccines and prolonged expression of immunogens |
| Q45411804 | Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines |
| Q41629004 | Plasmid DNA expression systems for the purpose of immunization |
| Q36488868 | Plasmid DNA vaccine-elicited cellular immune responses limit in vivo vaccine antigen expression through Fas-mediated apoptosis. |
| Q33732726 | Polynucleotide vaccines: potential for inducing immunity in animals |
| Q77735521 | Potential for plasmid DNAs as vaccines for the new millennium |
| Q37874110 | Protection of turkeys against Chlamydophila psittaci challenge by parenteral and mucosal inoculations and the effect of turkey interferon-gamma on genetic immunization. |
| Q36102001 | Regulatory T Cells Modulate DNA Vaccine Immunogenicity at Early Time via Functional CD4(+) T Cells and Antigen Duration |
| Q28475223 | Regulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbeta |
| Q36438450 | Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates |
| Q38189450 | Strategies and hurdles using DNA vaccines to fish. |
| Q37155956 | The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells |
| Q47315502 | The injection of plasmid DNA in mouse muscle results in lifelong persistence of DNA, gene expression, and humoral response. |
| Q47848931 | The protective mechanisms induced by a fish rhabdovirus DNA vaccine depend on temperature. |
| Q34005441 | The role of CpG in DNA vaccines |
| Q77419226 | The safety and longevity of DNA vaccines for fish |